160 related articles for article (PubMed ID: 6206061)
1. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates.
Cowan KH; Jolivet J
J Biol Chem; 1984 Sep; 259(17):10793-800. PubMed ID: 6206061
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.
Jolivet J; Schilsky RL; Bailey BD; Drake JC; Chabner BA
J Clin Invest; 1982 Aug; 70(2):351-60. PubMed ID: 6178756
[TBL] [Abstract][Full Text] [Related]
3. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
4. Insulin effects on methotrexate polyglutamate synthesis and enzyme binding in cultured human breast cancer cells.
Schilsky RL; Ordway FS
Cancer Chemother Pharmacol; 1985; 15(3):272-7. PubMed ID: 2414022
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, binding and intracellular retention of methotrexate polyglutamates by cultured human breast cancer cells.
Schilsky RL; Jolivet J; Bailey BD; Chabner BA
Adv Exp Med Biol; 1983; 163():247-57. PubMed ID: 6193688
[TBL] [Abstract][Full Text] [Related]
6. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
Allegra CJ; Boarman D
Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of methotrexate polyglutamation in human breast cancer cells.
Morrison PF; Allegra CJ
Arch Biochem Biophys; 1987 May; 254(2):597-610. PubMed ID: 2437860
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate polyglutamate synthesis by cultured human breast cancer cells.
Schilsky RL; Bailey BD; Chabner BA
Proc Natl Acad Sci U S A; 1980 May; 77(5):2919-22. PubMed ID: 6156458
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.
Barakat RR; Li WW; Lovelace C; Bertino JR
Gynecol Oncol; 1993 Oct; 51(1):54-60. PubMed ID: 7694891
[TBL] [Abstract][Full Text] [Related]
10. Insulin-dependent suppression in glutamyl hydrolase activity and elevated cellular methotrexate polyglutamates.
Galivan J; Rhee MS
Biochem Pharmacol; 1995 Nov; 50(10):1659-63. PubMed ID: 7503769
[TBL] [Abstract][Full Text] [Related]
11. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM; McGuire JJ
Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
13. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
Dixon KH; Trepel JB; Eng SC; Cowan KH
Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
[TBL] [Abstract][Full Text] [Related]
14. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
15. Wild-type and drug-resistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates.
Ellenberger TE; Wright JE; Rosowsky A; Beverley SM
J Biol Chem; 1989 Sep; 264(27):15960-6. PubMed ID: 2476435
[TBL] [Abstract][Full Text] [Related]
16. Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.
Pizzorno G; Mini E; Coronnello M; McGuire JJ; Moroson BA; Cashmore AR; Dreyer RN; Lin JT; Mazzei T; Periti P
Cancer Res; 1988 Apr; 48(8):2149-55. PubMed ID: 2450647
[TBL] [Abstract][Full Text] [Related]
17. Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line.
Rhee MS; Schneider E
Biochem Pharmacol; 2005 Jan; 69(1):123-32. PubMed ID: 15588721
[TBL] [Abstract][Full Text] [Related]
18. Enzyme studies of methotrexate-resistant human leukemic cell (K562) subclones.
Koizumi S; Allegra CJ
Leuk Res; 1992; 16(6-7):565-9. PubMed ID: 1378915
[TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.
Curt GA; Jolivet J; Carney DN; Bailey BD; Drake JC; Clendeninn NJ; Chabner BA
J Clin Invest; 1985 Oct; 76(4):1323-9. PubMed ID: 2414316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
